104 NDCs across 9 manufacturers|93 Generic,11 Brand
Temozolomide is used to treat glioblastoma and melanoma, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 11, 1999, and the first generic was approved Mar 1, 2010. FDA's Orange Book lists 58 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $39K on Temozolomide across 58 claims for 18 beneficiaries.
Temozolomide is available as 104 NDCs from 9 manufacturers (93 generic, 11 brand), with NADAC prices from $0.88 to $1091.67 per EA — the most expensive product costs about 1,241× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
104
93G / 11B
Manufacturers
9
competing in market
Price Spread
$0.88 – $1091.67
per EA
7d Activity
14↓90 flat
avg -5.0% WoW · of 104 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Temozolomide is used to treat glioblastoma and melanoma, per the National Library of Medicine's MED-RT classification.
When did Temozolomide become available as a generic?
FDA approved the first generic Temozolomide (ANDA) on Mar 1, 2010. The Orange Book currently lists 58 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Temozolomide?
In 2024, Medicare Part D spent $39K on Temozolomide across 58 claims for 18 beneficiaries.
How many Temozolomide products are on the market?
The Temozolomide drug market contains 104 NDCs from 9 manufacturers — 93 generic and 11 brand products.
What is the price range for Temozolomide?
NADAC reference prices for Temozolomide range from $0.8798 to $1091.6709 per EA — the most expensive product costs about 1,241× the cheapest.
Is generic Temozolomide cheaper than brand?
The average generic NADAC for Temozolomide is $15.6749 per EA, versus $329.2803 for brand-labeled products — brand versions average about 21× the generic price.
Which manufacturers make Temozolomide?
9 manufacturers list Temozolomide in NADAC. Ranked by number of NDCs, the largest are Sun Pharmaceutical Industries Inc. (21), Merck Sharp & Dohme LLC (11), Camber Pharmaceuticals Inc. (11), Rising Pharma Holdings Inc. (11), Accord Healthcare Inc. (11).
How has the price of Temozolomide changed recently?
Over the past 7 days, 0 Temozolomide NDCs rose and 14 fell, with a market-wide average change of -5.0%.